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The TAN-1 gene was originally discovered at the 
breakpoint of a recurrent (7;9)(q34;q34.3) chromosom- 
al translocation found in a subset of human T-lympho- 
blastic leukemias (Reynolds et al. 1987; Smith et al. 
1988; Ellisen et al. 1991). This translocation joins 
roughly the 3' half of TAN-1 head-to-head with the 3' 
portion of the/3 T-cell-receptor gene (TCRB) begin- 
ning at the 5' boundary of one or the other J segment. 
Intact TAN-1 is normally transcribed into an 8.2-kb 
transcript hat is present in many tissues, most abun- 
dantly in developing thymus and spleen (Ellisen et al. 
1991). This tissue distribution and the apparent in- 
volvement of an altered version of the gene in T-cell 
cancers have suggested that TAN-1 normally has some 
special function in lymphocytes or their precursors. 
Nucleotide sequence analysis of the TAN-1 tran- 
script has revealed a single open reading frame of 2555 
codons. The predicted amino acid sequence is highly 
homologous to the product of the Drosophila gene 
Notch. This gene encodes a transmembrane protein 
that has been implicated in cell fate decisions between 
alternative differentiative pathways in a variety of tis- 
sues during both embryonic and adult fly development. 
Most data suggest hat the protein product of Notch 
functions as a receptor in a signaling pathway (Fortini 
and Artavanis-Tsakonis 1993; Ghysen et al. 1993). The 
similarity of the TAN-1 and Notch proteins (referred to 
here as tan-1 and notch) includes a series of shared 
sequence motifs within the primary structures of the 
two proteins (summarized in Fig. 1). Other Notch 
homologs have been identified recently in mice (Franco 
del Amo et al. 1992; Reaume et al. 1992; Lardelli and 
Lendahl 1993), rats (Weinmaster et al. 1991, 1992), 
zebrafish (Bierkamp and Campos-Ortega 1993), and 
Xenopus (Coffman et al. 1990). In mice, there are at 
least three closely related homologs, Notch1-3, in addi- 
tion to one more distantly related homolog, Int-3, 
which shares most structural motifs with the other 
genes (Robbins et al. 1992). A partial sequence of 
human Notch2, termed hN (Stifani et al. 1992), has also 
been reported, indicating the existence of a Notch gene 
family in humans as well as mice. 
We decided to investigate the TAN-1 gene and its 
role in oncogenesis for a number of reasons. First, 
homology between genes at chromosomal breakpoints 
in human cancers and developmental genes from Dro- 
sophila has become a common theme in molecular 
oncology. TAN-1 was among the first such genes iden- 
tified, and we were interested in the interrelationship 
between tumor formation and normal differentiation. 
We were also curious about the significance of altera- 
tions in TAN-1 with respect o malignant transforma- 
tion. The karyotypes of neoplasms with the 
t(7;9)(q34;q34.3) contain few other cytogenetic abnor- 
malities. Nevertheless, it is always possible that certain 
obscure mutations play a more fundamental role in 
transformation and that translocations involving TAN- 
1 merely provide some marginal proliferative or surviv- 
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Figure I. Schematic representation f the tan-1 protein and 
polypeptides xpected to be expressed from various cDNA 
constructs. The positions of structural motifs within the full- 
length protein based on the cDNA sequence are shown at the 
top. (L) Leader sequence; (EGF repeats) epidermal growth 
factor-like repeated sequences; (BP) position at which the 
amino acid sequence of tan-1 would be disrupted by the 
breakpoints in the t(7;9)(q34;q34.3) in all such translocations 
analyzed to date; (lin-12 repeats) repeated sequences resem- 
bling those found in the Lin-12 gene of C. elegans; (SS) highly 
conserved cysteines found in all Notch-related genes and 
located 49 and 42 amino acids external to the transmembrane 
domain in tan-l; (TM) transmembrane domain; (1 and 2) two 
putative nuclear localization signals; (T3) region between the 
transmembrane domain and the ankyrin repeats used as an 
immunogen; (TAR) ankyrin-like repeats; (O) glutamine and 
proline-rich region resembling an opa sequence; (P) region 
containing proline, glutamate, serine, and threonine, which 
resembles a PEST sequence. Portions of the full-length tan-1 
protein expected to be expressed by the cDNA constructs are 
shown as solid lines at the bottom; interstitial deleted seg- 
ments are indicated by dashed lines. 
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al advantage to cells that had already undergone trans- 
formation due to the effects of these other mutations. 
Additionally, the fact that only a fraction (perhaps 3- 
5%) of T-lymphoblastic neoplasms contain the 
t(7;9)(q34;q34.3) and that these neoplasms are not 
readily distinguishable from other T-lymphoblastic 
tumors by any outstanding morphological, histochem- 
ical, or immunologic feature also suggests that altera- 
tions in TAN-1 may constitute only a secondary phe- 
nomenon which follows the primary transformation 
event. Finally, we believed that insights into the func- 
tion of any of the several structural motifs within tan-1 
might provide clues to the role of similar regions in the 
relatively large number of proteins that share these 
motifs. With these considerations in mind, we have 
proceeded in analysis of the TAN-1 gene along five 
different lines of investigation: (1) structural characteri- 
zation of tan-1 in cells with and without the 
t(7;9)(q34;q34.3); (2) analysis of the subcellular loca- 
tion of tan-l; (3) in vivo transformation of murine bone 
marrow stem cells by TAN-1 cDNA; (4) identification 
of an intracellular ligand of tan-l; and (5) detection of a 
possible role for tan-1 in transcriptional ctivation. 
EXPERIMENTAL PROCEDURES 
Materials. Enzymes used in cloning procedures 
were obtained from New England Biolabs. Unless 
otherwise indicated, cell culture reagents were obtained 
from Gibco-BRL. 
Cells and cell lines. The cell lines SUP-T1 and 
Jurkat were grown in RPMI 1640 supplemented with 
10% heat-inactivated fetal calf serum. 293T cells were 
grown in Dulbecco's modified Eagle's medium sup- 
plemented with 10% heat-inactivated calf serum; NIH- 
3T3 cells were grown in the same medium sup- 
plemented with 10% donor calf serum. 
Synthesis of cDNA expression constructs. TAN-1 
constructs were assembled from previously described 
cDNAs (Ellisen et al. 1991) using standard cloning 
methods. DNA sequences encoding various portions of 
the protein (Fig. 1), including the TAN-1 translational 
start site and 5' signal peptide, the T3 region, and the 
TAR region, were amplified from cDNA templates by 
PCR. The cDNA expression constructs assembled from 
these PCR products encode the following polypeptides: 
TAN-l, amino acids 19-2555; AECT+ S(L), amino 
acids 1673-2555; AECT-S(L), amino acids 1704-2555; 
ICT, amino acids 1768-2555; T3, amino acids 1762- 
1879; TAR, amino acids 1872-2150. AL-S was derived 
from the full-length cDNA by creating an internal 
deletion that removed base pairs 4684-5109 (codons 
1562-1703). 
Construction and in vitro transcription~translation 
of a full-length BCL-3 cDNA. An overlapping 3' 
fragment of the BCL-3 eDNA encoding the carboxyl 
terminus of the protein was PCR amplified from a 
cDNA library prepared from Jurkat cell poly(A) + 
RNA. This fragment was ligated to the 5' end of the 
BCL-3 cDNA that had been isolated from the human 
endothelial cell cDNA library. The BCL-3 construct 
was ligated into pBluescript and the structure con- 
firmed by both restriction endonuclease digestion and 
DNA sequence analysis. Deletion constructs were pre- 
pared by PCR of the full-length BCL-3 cDNA using 
appropriate oligonucleotide primer pairs. In vitro tran- 
scription with T3 RNA polymerase was performed 
according to the recommendations of the supplier 
(Stratagene). In vitro translation of the BCL-3 tran- 
scripts was performed in a rabbit reticulocyte lysate in 
the presence of [35S]methionine according to the rec- 
ommendations of the manufacturer (Stratagene). 
Polypeptide synthesis and antibody prepa- 
ration, cDNAs encoding the T3 and TAR regions of 
tan-1 were cloned into the vector pGEX-4T (Phar- 
macia) and expressed in Escherichia coli as glutathione- 
S-transferase (GST) fusion proteins. GST, GST-T3, 
and GST-TAR were purified from bacterial extracts by 
affinity chromatography on glutathione-Sepharose col-
umns (Pharmacia). Chickens and rabbits were immu- 
nized with purified antigen emulsified in Freund's 
complete adjuvant and boosted periodically with an- 
tigen in Freund's incomplete adjuvant. Serum from 
immunized chickens and rabbits was cleared of anti- 
body against GST by passage over a GST-AffiGel 
column (BioRad), and the flowthrough was then ap- 
plied to AffiGel-GST-T3 or AffiGel-GST-TAR col- 
umns. Bound antibody was eluted with 0.2 M glycine 
(pH 2.7), neutralized with 1 M Tris (pH 8.0), and 
dialyzed against PBS. 
Transient and stable expression of cDNA. For 
transient expression studies, cDNAs were cloned into 
the BamHI site of the vector pcDNAI (Invitrogen). 
293T cells were transfected with CsCl-banded DNA 
using a modified calcium phosphate precipitation meth- 
od (Pear et al. 1993). For stable expression studies, 
cDNAs were cloned into the BclI site of the retroviral 
shuttle vector pGD (Daley et al. 1990). Helper-free 
retroviral stocks produced by transfection of the pack- 
aging cell line Bosc23 were used to infect NIH-3T3 cells 
(Pear et al. 1993), and cells containing stably integrated 
provirus were selected with G418 (1 mg/ml). 
Bone marrow transplantation. Transfection of 
Bosc23 cells with retroviral vectors, cocultivation of 
Bosc23 cells and mononuclear cells isolated from 5-FU- 
treated bone marrow, and injection of infected mono- 
nuclear cells into lethally irradiated BALB/cByJ recipi- 
ents were performed as described previously (Pear et 
al. 1993). 
Preparation and Western blot analysis of protein 
extracts. Protein extracts were prepared from cell 
lines and peripheral blood mononuclear cells using 
RIPA (50 mM Tris [pH 7.4] containing 150 mM NaC1, 1 
mM EDTA, 1% NP-40, 0.5% sodium deoxycholate, 
0.1% SDS, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 
mM PMSF) by standard methods (Harlow and Lane 
1988). For Western blot analysis, proteins were subject- 
ed to discontinuous polyacrylamide gel electrophoresis 
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(SDS-PAGE) (Laemmli 1970) and transferred to nitro- 
cellulose membranes (Towbin et al. 1979). Blots were 
blocked and incubated with primary and secondary 
antibodies as described previously (Dutta et al. 1993). 
Blots were developed using the ECL method (Amer- 
sham). 
Western blots using radiolabeled GST-TAR as probe 
(Far Western blots) were performed on bacterial cell 
extracts prepared by sonication in the presence of 0.5% 
NP-40. Extracts were fractionated by SDS-PAGE and 
proteins were transferred to nitrocellulose (in the ab- 
sence of methanol) by electroelution. The filters were 
blocked with 5% milk. Proteins were renatured by 
washing in a decreasing uanidine-HC1 gradient. GST- 
TAR fusion protein was radiolabeled with 32p and 
bovine heart muscle kinase according to the method of 
Kaelin et al. (1992). Binding of radiolabeled GST-TAR 
was performed overnight at 4~ in HYB-75 (20 mM 
HEPES [pH 7.7], 75 mM KCI, 0.05% NP-40, 0.1 mM 
EDTA, 2.5 mM MgClz) and 1% milk. Filters were 
washed in HYB-75 at 4~ Identical binding and wash 
conditions were used to screen the human endothelial 
cell cDNA library in ,~gtll (Blackwood and Eisenman 
1991; Kaelin et al. 1992). 
lmmunoprecipitation of metabolically labeled 
polypeptides. For standard immunoprecipitations, 
about 5 • 106 Jurkat or SUP-T1 cells were washed with 
Hank's buffered saline and incubated twice for 1 hour 
at 37~ in methionine-free RPMI 1640 containing 10% 
dialyzed fetal calf serum (Sigma). Cells were then 
incubated for 3 hours in fresh methionine-deficient 
media supplemented with 100 mCi to 1 mCi of 
[35S]methionine (New England Nuclear). For pulse- 
chase analysis, 5 • 107 cells depleted of methionine as 
described above were resuspended in 8 ml of warm 
(37~ methionine-deficient medium containing 5 mCi 
of [35S]methionine. After 10 minutes at 37~ cells were 
spun at 500g for 5 minutes, washed once with complete 
medium, and resuspended in 40 ml of complete 
medium containing 2 mM unlabeled methionine. At 
various time points thereafter, 5-ml aliquots were re- 
moved and diluted into 15 ml of ice-cold Hank's buf- 
fered saline, and then washed once with ice-cold 
Hank's buffered saline. RIPA extracts prepared from 
washed cell pellets were "cleared" by mixing for 30 
minutes at 4~ with 20 /xl of protein A-Sepharose 
beads (Pharmacia). After centrifugation, supernatants 
were incubated with 1 txl of rabbit anti-T3 serum for 1 
hour at 0~ then mixed with 20 /xl of protein A -  
Sepharose beads for 30 minutes at 4~ Beads were 
washed 3 times with RIPA and boiled for 10 minutes in 
0.1 ml of 0.5% SDS. Supernatants were adjusted to 
RIPA conditions (final volume, 0.5 ml), and cross-re- 
active polypeptides were reprecipitated asabove using 
1 /xl of rabbit anti-TAR serum. Control immuno- 
precipitates were prepared by sequential incubation 
with pre-immune sera. 
Peptide mapping. Proteins were metabolically 
35 labeled with [ S]methionine, immunoprecipitated, and 
subjected to discontinuous SDS-PAGE. After visualiza- 
tion of the position of bands by fluorography, one- 
dimensional peptide maps were prepared from excised 
bands using V8 protease (Cleveland et al. 1977). 
Immunolocalization. For immunoperoxidase tain- 
ing, 1 • 104 SUP-T1 or Jurkat cells were deposited on 
slides by cytocentrifugation. For immunofluorescent 
staining, cells were grown on 8-chamber slides (Lab- 
Tek, Permanox). In each case, cells were fixed in 2% 
paraformaldehyde, permeabilized in -20~ methanol, 
and stained with affinity-purified rabbit anti-tan-1 anti- 
bodies using previously described incubation and wash- 
ing conditions (Pinkus et al. 1985). 
RESULTS 
Structural Analysis of tan-1 in Cells 
with and without the t(7;9) 
To investigate the structure of the tan-1 proteins 
produced in cells containing or lacking the 
t(7;9)(q34;q34.3), antibodies raised against portions of 
the cytoplasmic domain of tan-1 were used in Western 
blot analysis of whole-cell extracts prepared from SUP- 
T1 and Jurkat cells (Fig. 2). SUP-T1 is a cell line 
established from a T-lineage lymphoblastic lymphoma 
that contained two identical copies of the t(7;9) 
(q34;q34.3), no normal chromosome 9, and therefore 
no normal copy of TANol. Jurkat, a control cell line 
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Figure 2. Western blot of cross-reacting polypeptides detected 
with anti-tan-1 antibodies. Whole-cell protein extracts from 
Jurkat cells (50 p,g ofprotein), SUP-T1 cells (50 Izg), or 293T 
cells (500 ng) transiently transfected with empty vector or 
vector carrying TAN-1 cDNAs were fractionated by SDS- 
PAGE in 6% gels prior to electrophoretic ransfer to nitro- 
cellulose. After incubation with affinity-purified chicken anti- 
T3 antibody (1 /~g/ml) and secondary rabbit anti-chicken 
antibody linked to horseradish peroxidase (1:2500), cross-re- 
active polypeptides were detected using chemiluminescence. 
The positions of size markers are shown in kilodaltons at the 
left. 
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known abnormality of chromosome 9 or TAN-I. Initial 
studies performed with antibodies raised in chickens 
against a portion of the cytoplasmic domain close to the 
transmembrane domain (termed T3; see Fig. 1) de- 
tected a series of bands in SUP-T1 extracts corre- 
sponding to polypeptides of - 125-100 kD. This anti- 
body also detected two major bands in Jurkat 
extracts--one band corresponding to a large polypep- 
tide of - 350 kD (hereafter referred to as p350) and a 
second band corresponding to a smaller polypeptide of 
120 kD (referred to as p120). The size of the p350 
polypeptide is compatible with that predicted for the 
full-length tan-1 protein, and the size of the p120 
polypeptide matches that observed for one of the major 
truncated products present in SUP-T1 cells. 
Other antisera raised in chickens and rabbits against 
T3 and the region (termed TAR) containing a series of 
six so-called ankyrin-like repeats also recognized p350 
and p120 in extracts from Jurkat cells and polypeptides 
of 100-125 kD in extracts from SUP-T1 cells (not 
shown), suggesting that these polypeptides are encoded 
by the wild-type and t(7;9)(q34;q34.3) TAN-1 alleles, 
respectively. The specificity of various antibodies was 
confirmed in several ways. The polypeptides detected 
with affinity-purified antibodies against an-1 were not 
stained by pre-immune sera, and staining with specific 
antibody was inhibited by pre-incubation with purified 
antigen. Furthermore, Western blots of extracts from 
293T cells transiently transfected with expression vec- 
tors containing full-length TAN-1 cDNAs showed 
greatly increased levels of cross-reacting polypeptides. 
To characterize the structure of the various cross- 
reactive polypeptides found in Jurkat and SUP-T1 cells, 
full-length TAN-1 cDNAs and cDNAs carrying dele- 
tions from the 5' end of the gene were transiently 
transfected into 293T cells (Figs. 1 and 2). Transfection 
with the full-length cDNA resulted in expression of a 
series of polypeptides, the most prominent of which 
was close to the size of p350. In contrast, the sizes of the 
largest of the SUP-T1 polypeptides and p120 were 
similar to sizes of polypeptides ncoded by cDNAs with 
deletions removing most of the coding sequence for the 
extracellular domain of tan-1. To further study the 
structural similarities between polypeptides, a method 
for specific immunoprecipitation of cross-reactive poly- 
peptides was developed (Fig. 3A). Partial digestion of 
35S-labeled immunoprecipitated proteins with V8 
protease generated a set of comparable bands in one- 
dimensional gels from p120 and several of the truncated 
polypeptides of SUP-T1 (Fig. 3B). Therefore, the 
compositions of p120 and the truncated polypeptides 
associated with chromosomal translocation appear 
similar. Partial digestion of a polypeptide precipitated 
from 293T cells transfected with a truncated cDNA 
construct, AECT-S(L), yielded a one-dimensional map 
closely corresponding to that of p120 and the largest 
truncated polypeptides of SUP-T1. This expression 
construct encodes a mature polypeptide with an amino 
terminus at codon 1703, a position 30 amino acids 
external to the transmembrane domain and just inter- 
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Figure 3. Peptide mapping of tan-l-related polypeptides. (A) 
Immunoprecipitations f tan-1 polypeptides from extracts of 
Jurkat and SUP-T1 cells. Cells were metabolically abeled with 
[35S]methionine and proteins were immunoprecipitated with 
rabbit anti-T3 antiserum, followed by resolubilization f com- 
plexes by boiling and reprecipitation with rabbit anti-TAR 
antiserum. Control immunoprecipitations were performed 
with rabbit anti-GST antiserum during the first stage. Results 
were analyzed by SDS-PAGE in a 6% gel and fluorography of
the gel. Comparison to the results in Fig. 2 demonstrates the 
specificity of sequential immunoprecipitation using the two 
antisera. (B) Peptide mapping of immunoprecipitated protein 
performed as in A. Immunoprecipitation was carried out on 
the NIH-3T3 cells infected with pGD-TAN-I, transiently 
transfected 293T cells, and Jurkat and SUP-T1 cells metaboli- 
cally labeled with [35S]methionine. Precipitated polypeptides 
were separated by SDS-PAGE, located by fluorography, ex- 
cised from the gel, and subjected to partial proteolysis with 50 
ng or 500 ng of V8 protease during electrophoresis in 12% 
polyacrylamide g ls. 
nal to two conserved cysteine residues encoded by 
codons 1683 and 1690. Maps of polypeptides from cells 
transfected with cDNA constructs including more or 
less coding sequence near this site (e.g., AECT + S[L] 
and ICT) differed from maps of p120 and the truncated 
polypeptides. Therefore, the amino terminus of p120 
and the largest truncated polypeptides in SUP-T1 are 
very close and possibly just carboxy-terminal to the two 
conserved cysteines. 
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These data show that the size and structure of the 
tan-1 polypeptides found in extracts of SUP-T1 are 
consistent with translation of polypeptides from a trun- 
cated TAN-1 transcript. Northern blot analyses of 
SUP-T1 cells have shown the presence of abundant 
novel mRNA species that are derived from the 3' 
portion of TAN-1 and vary from 4 to 6 kb (Ellisen et al. 
1991), suggesting activation of cryptic promoters in 
DNA near the breakpoint. The exact positions of the 
transcriptional start sites are not known and could be 
either 5' or 3' of the breakpoint. The precise transla- 
tional start site or sites are also uncertain. The translo- 
cation breakpoint in SUP-T1 cells and two other 
tumors containing the t(7;9)(q34;q34.3) lie in an intron 
within DNA encoding EGF repeat 34, such that the 
first in-frame codon 3' of the breakpoint in all tumors 
begins at bp 4015 of the cDNA (Ellisen et al. 1991). 
Transfection of 293T cells with a cDNA beginning at bp 
4015 and continuing through the 3' stop codon results 
in synthesis of several polypeptides of lower abun- 
dance, which are larger than those seen in SUP-T1 cells 
(not shown). This suggests that sequences 3' of the 
breakpoint that normally are intronic may contribute 
one or more translational start sites, and raises the 
possibility that some of the cross-reactive polypeptides 
in SUP-T1 cells have sequences at their amino termini 
found nowhere in the full-length protein. If such se- 
quences exist, however, they are not required for on- 
cogenesis (see below). 
The results of Western blots and peptide mapping 
suggested that p120 is generated by proteolytic leav- 
age of p350. This interpretation is consistent with the 
presence of a band at the 120 kD position in blots of 
extracts from 293T cells and NIH-3T3 cells transiently 
or stably overexpressing full-length TAN-1 cDNA, 
respectively. Northern blots of Jurkat RNA also sup- 
port this interpretation, since these analyses fail to 
show TAN-1 transcripts other than the 8.2-kb species. 
Therefore, translation of p120 from either an alter- 
natively spliced mRNA or a transcript originating from 
a second internal promoter is unlikely. 
To confirm that p350 is the precursor of p120, a 
pulse-chase analysis was performed with Jurkat cells. 
This demonstrated a clear inverse relationship between 
the amount of p350 and p120, with progressively more 
p120 accumulating over time (Fig. 4A). These results 
are compatible with the derivation of p120 from p350 
by proteolytic leavage. On the basis of peptide map 
data, it was predicted that this cleavage site should be 
just external to the transmembrane domain. This con- 
clusion is supported by inhibition of proteolytic pro- 
cessing by a deletion removing the amino acid sequence 
between the lin-12 repeats and the transmembrane 
domain (Fig. 4B). 
Analysis of the Subcelhlar Location of tan-1 
The location of tan-1 proteins within cells was 
studied by immunofluorescence and immunohisto- 
chemistry using the anti-T3 and anti-TAR antibodies. 
A 
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Figure 4. Processing of full-length tan-1 protein. (A) Pulse- 
chase analysis. Jurkat cells were metabolically abeled with 
[35S]methionine for 10 min, resuspended in medium contain- 
ing unlabeled methionine, and harvested thereafter at inter- 
vals shown at the top of the figure. Polypeptides were im- 
munoprecipitated and analyzed as in Fig. 3A. (B)Western blot 
analysis of NIH-3T3 cells stably expressing tan-1 from ret- 
roviral vectors. Whole-cell extracts were prepared from cells 
infected by the pGD vector containing no cDNA insert, a 
full-length TAN-1 cDNA, or a TAN-1 cDNA deleted for a 
region lying between the lin-12 repeats and the transmem- 
brane domain (AL-S). From each extract, 10/zg was analyzed, 
using chicken anti-T3 antibody as in Fig. 2. 
Because cells lacking the t(7;9)(q34;q34.3) showed only 
weak staining with these reagents, attempts were made 
to determine the normal location of tan-1 by infecting 
NIH-3T3 cells with a recombinant retrovirus that 
produces relatively large amounts of p350 and pro- 
cessed p120. This procedure resulted in staining of the 
cytoplasm in a speckled, perinuclear pattern, suggesting 
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localization to the endoplasmic reticulum (Fig. 5A). 
The N-linked glycosyl residues of p350 were also found 
to be endoH-sensitive (J. Aster and J. Sklar, unpubl.), 
further supporting retention of tan-1 in the endoplas- 
mic reticulum. Similar cytoplasmic retention of notch 
has been demonstrated in overexpressing insect cells, 
although both notch and tan-1 are predicted to function 
as transmembrane r ceptors and therefore to be ex- 
pressed on plasma membrane. These findings indicate 
that surface expression of tan-1 and notch may be 
tightly regulated and dependent on cofactors which 
have yet to be discovered. 
In contrast to the cytoplasmic location of tan-1 in 
cells expressing full-length tan-l, cross-reacting poly- 
peptides were found predominantly in the nuclei of 
SUP-T1 cells (Fig. 5B). This staining pattern was also 
observed in 293T cells transiently expressing the cyto- 
plasmic domain (ICT) of tan-1 (Fig. 5C). Since the 
polypeptides expressed in SUP-T1 lack signal peptides, 
insertion of these polypeptides into membranes may 
occur inefficiently or not at all, thereby explaining the 
difference in subcellular localization of these polypep- 
tides and polypeptides encoded by the AECT(L) ex- 
2 
pression constructs. Taken together, these findings 
imply that signals permitting efficient nuclear transport 
exist within the intracellular portion of tan-1. Four 
short stretches of intracellular sequence relatively rich 
in basic amino acids represent potential nuclear locali- 
zation signals (NLSs). The first two of these lie within 
the T3 region of the protein, and the other two lie just 
carboxy-terminal to the ankyrin repeats. Deletion of 
both of these regions led to retention of most of the 
tan-1 polypeptide in the cytoplasm (Fig. 5D). Deletion 
of either region separately was much less effective in 
causing the redistribution of protein from nucleus to 
cytoplasm, indicating an additive effect of NLSs in 
these two regions. 
In Vivo Transformation of Murine Bone Marrow 
Stem Cells by TAN-I  cDNA 
The role of tan-1 protein in malignant transformation 
was directly tested by transduction of truncated TAN-1 
cDNAs into murine bone marrow cells and infusion of 
these cells back into lethally irradiated syngeneic m e. 
Two cDNA constructs, AECT + S(L) and AECT-S(L), 
.3 
Figure 5. Immunolocalization f tan-1 polypeptides within tissue culture cells. (A) NIH-3T3 cells infected with t e retrovirus 
pGD-TAN-1, overexpressing full-length tan-l; (B) SUP-T1 cells; (C) 293T cells transiently transfected with expression vectors 
carrying a cDNA construct for the cytoplasmic domain of TAN-1 (ICT); and (D) 293T cells transiently transfected with an 
expression vector identical to that in C, except for the deletion from the TAN-1 coding sequence of two putative nuclear 
localization signals (ICTAT3AN2). Cells in each panel were stained with affinity-purified rabbit anti-T3 oranti-TAR antibodies, 
followed by sheep anti-rabbit antibody linked to fluorescein thiocyanate (A, C, and D) or goat anti-rabbit antibody linked to 
horseradish peroxidase (B). Cells in A, C, and D were photographed through a fluorescence microscope. Cells in B were 
photographed through a standard visible light microscope after developing the image by incubation with diaminobenzidine and 
counterstaining with methyl green. Magnification, 650 • 
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were inserted into the retroviral shuttle vector pGD, 
which was transfected into the packaging cell line 
Bosc23. Bone marrow mononuclear cells were infected 
with the resultant helper-free retrovirus by co-cultiva- 
tion with the Bosc23 cells. Following transplantation, 
mice were monitored by biweekly bleeding and by 
observation for cachexia. Mice with significantly ele- 
vated leukocyte counts or grossly apparent disease 
were sacrificed and autopsied. 
To date, 7 of 20 mice have developed leukemia with a 
latency of between 11 and 40 weeks posttransplanta- 
tion. Mice that developed leukemia were observed with 
both cDNA constructs (Table 1). Flow cytometry indi- 
cated that the leukemic cells in each case had an 
antigenic profile compatible with an immature T-cell 
phenotype. All tumors have proven to be readily trans- 
plantable into syngeneic recipients, and one stable cell 
line has been derived (T6E). 
Immunostaining of various tissues with tan-1 anti- 
bodies demonstrated high levels of cross-reactive pro- 
tein in infiltrating tumor cells relative to surrounding 
normal tissue (not shown). To determine the intracellu- 
lar distribution of staining, additional immunohisto- 
chemistry was performed on cytospin preparations of 
the T6E cell line and disaggregated tumors. This analysis 
revealed most staining to be cytoplasmic n a vesicular, 
perinuclear distribution, with less intense nuclear mem- 
brane staining evident in a subset of cells (Fig. 6A). The 
precise identity of the vesicular structures is not yet 
known. Western blot analysis performed on extracts of 
these tissues with anti-T3 and anti-TAR antibodies 
detected one to several prominent bands at the position 
of polypeptides of about 120 kD, the approximate size 
of the products expected to be synthesized from the 
AECT + S(L) and AECT-S(L) cDNA constructs (Fig. 
6B). Additionally, particularly in extracts prepared 
from the T6E cell line, a band of about 350 kD was also 
present, corresponding to the size of full-length notch- 
related proteins. Further work has shown that this band 
also cross-reacts with an antibody directed against a 
region just amino-terminal of the opa sequence (J. 
Aster et al., unpubl.). This region is found in murine 
tan-1 (notchl), but is absent from notch2, notch3, and 
int-3, suggesting that the cross-reactive band is the 
product of endogenous murine Notch1. It is unclear 
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Figure 6. Analysis of tan-1 polypept ide in mur ine  leukemias 
induced by infection of bone marrow cells with retroviral  
vectors carrying deleted forms of the TAN-1 cDNA.  (A) 
Immunoloca l i zat ion  f  tan-1 polypept ide in the T6E  in vitro 
cell line. The  cells were  stained with rabbit  anti-T3 ant ibody 
and the image was deve loped and photographed as in Fig. 5B. 
Magnif ication, 650 x .  (B)  Western blot analysis of extracts 
p repared  f rom organs of leukemic mice which showed heavy  
visceral invo lvement  by tumor  and f rom organs of normal  
BALB/c  control  animals. T1, 4, 6, and 8 correspond to the 
designations in Table  1. Ten  /zg f rom each extract were  
analyzed in Western blots using rabbit  anti-T3 antibody. 
Tab le  1. Characterist ics of Lymphoblast ic  Neop lasms Ar is ing in Mice Which Underwent  Transplantat ion with Bone 
Marrow Infected with Retroviral Vectors Carrying AECT + S(L) and AECT-S(L) cDNAs. 
Sites of gross involvement FACS 
Animal Cys latency Terminal node spleen liver thymus CD3 CD4 CD8 /3 2 ~ 
# repeats (weeks) WBC (k//zl) mice 
T1 - 11 70 + + - - + + + + + 
T3 - t6 4 . . . .  + - + + + 
T4 - 12 68 + + + - + + + + + 
T6 + 15 42 + + - + + - + + + 
T7 + 40 65 + + + + n.d. - - n.d. n.d. 
T8 + 15 41 + + - + + + + + 
T14 + 16 55 + + - - + + + + + 
The first three mice received AECT-S(L) (indicated by - in the second column) and the next four AECT + S(L) (indicated by + in the second 
column). FACS = results of flow cytometry, n.d. = not done. WBC = white blood cell count. /3 = T-cell receptor/3 chain. 
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whether expression of notchl is due to induction by the 
truncated tan-1 protein or to the selective transforma- 
tion of T-cell precursors in which the gene is normally 
expressed. 
Southern blot analysis with probes specific for the 
retroviral vector sequences has shown that six of seven 
tumors analyzed contain a single integrated provirus, 
with the seventh having two proviruses (not shown). 
Southern blot analyses howed that all sites of insertion 
into the genome were unique. Additionally, analyses 
with J/31 and J/32 probes indicated that all tumors 
except for that in animal T6 had clonal rearrangements 
of the/3 T-cell-receptor gene. 
These studies demonstrate that tumors arising in 
recipients of marrow infected with retrovirus carrying 
truncated forms of TAN-1 develop clonal T-lympho- 
blastic neoplasms at high frequency. An additional 
seven tumors have now been observed in other trans- 
plant cohorts, all of which have also demonstrated an 
immature T-cell phenotype (W.S. Pear et al., unpubl.), 
further emphasizing the T-cell oncotropism of TAN-1. 
In contrast, of approximately 200 animals receiving 
marrow transduced with pGD carrying other cDNA 
constructs, none has developed a T-cell tumor (W.S. 
Pear et al., unpubl.). Although recombination of defec- 
tive retrovirus with an endogenous provirus to produce 
competent Moloney leukemia virus is a theoretical 
concern, transcripts encoding the Moloney envelope 
have not been detected in leukemic animals (W.S. Pear 
et al., unpubl.), making this possibility unlikely. 
Identification of an lntracellular Ligand 
of tan-1 Protein 
The presence of both large extracellular and intracel- 
lular domains within the tan-1 protein suggests that this 
molecule may mediate the transduction of some signal 
across the plasma membrane by binding or interacting 
with ligands on either side of the membrane. Indeed, in 
Drosophila, direct physical interaction has been dem- 
onstrated between the extracellular portion of notch 
and the protein products of two genes, Delta and 
Serrate (Rebay et al. 1991). Our initial efforts to iden- 
tify ligands of tan-1 have concentrated on the intracel- 
lular region of the molecule. Since ankyrin repeats have 
been implicated previously in interactions between 
other proteins (Lux et al. 1990; Nolan and Baltimore 
1992), we have searched for ligands that might bind to 
the region of tan-1 containing these repeats. 
A 750-bp fragment encoding the ankyrin repeats 
(TAR) was amplified by PCR from the cloned TAN-1 
cDNA, ligated into the bacterial glutathione-S-trans- 
ferase (GST) expression plasmid pGEX2TK, and ex- 
pressed in E. coli as a fusion polypeptide with GST at 
the amino terminus. The GST-TAR fusion polypeptide 
labeled with 32p was then used to screen plaques for 
TAR-binding proteins from a human endothelial cell 
cDNA library cloned in Agtll (Ginsburg et al. 1985). 
This randomly primed cDNA library was chosen for 
screening because it is known to be highly representa- 
tive of a vast array of RNAs and because it is the same 
library from which cDNA on the 5' end of the TAN-1 
mRNA was originally isolated (Ellisen et al. 1991). 
Several plaques showed binding of the GST-TAR fu- 
sion polypeptide in this assay. Bacteriophage from the 
single plaque that continued to show binding after three 
rounds of screening were purified, and the nucleotide 
sequence of the cDNA inserted within the vector DNA 
was determined. Comparison of sequences in the Gen- 
Bank database demonstrated a match between the 
isolated cDNA and a large 5' fragment of the coding 
sequence for the gene BCL-3. 
To confirm the binding of the GST-tan-1 fusion 
polypeptide to bcl-3, portions of the BCL-3 cDNA 
were inserted into the pGEX2TK plasmid, and GST- 
bcl-3 fusion polypeptides were expressed in E. coli. 
Protein extracts from these bacteria were separated in 
SDS-polyacrylamide g ls and transferred to nitrocellu- 
lose membranes. The membranes were then incubated 
with radiolabeled GST-TAR fusion polypeptide. Auto- 
radiograms of the membranes revealed that the GST- 
TAR polypeptide had specifically bound the amino- 
terminal fragment of bcl-3 protein containing the first 
six of the seven ankyrin repeats found in bcl-3 (Fig. 
7A). As few as three bcl-3 ankyrin repeats were suffi- 
cient for some residual binding by GST-TAR. To dem- 
onstrate that the interaction between TAR and bcl-3 
polypeptides was not due to an artifact arising from 
truncations of the bcl-3 polypeptide, full-length bcl-3 
radiolabeled with [35S]methionine was synthesized in 
vitro. Bcl-3 protein synthesized in this fashion bound to 
GST-TAR glutathione-Sepharose beads, but not GST 
glutathione-Sepharose beads (Fig. 7B). 
Direct co-immunoprecipitation of tan-1/bcl-3 com- 
plexes with anti-tan-1 and/or anti-bcl-3 antibodies from 
tissue culture cells was complicated by the low amounts 
of bcl-3 produced in most cells and by the low affinity of 
the anti-bcl-3 antibodies which we have either pro- 
duced ourselves or obtained from other sources. To 
overcome the problem of low antigen concentration 
within cells, we have conducted co-immunoprecipita- 
tion studies using transfected 293T cells co-expressing 
epitope-tagged bcl-3 and various forms of tan-1. For 
these studies, the BCL-3 cDNA was inserted into the 
vector pCGN, which produces a fusion polypeptide 
containing an epitope from the influenza virus hemag- 
glutinin (HA) at the amino terminus of the fusion 
protein. Immunoprecipitates of extracts from the doub- 
ly transfected cells using the mouse monoclonal anti- 
body 12CA5, which recognizes the HA epitope, 
brought down p350 together with p120 tan-1 polypep- 
tides presumably bound to the HA-bcl-3 fusion protein 
(Fig. 7C). These data demonstrate that interaction of 
tan-1 and bcl-3 can occur in intact cells. 
Evidence of a Possible Role for tan-1 in 
Transcriptional Activation 
We unexpectedly uncovered evidence suggesting a
possible role for tan-1 in transcriptional activation 
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Figure 7. Analysis of protein-protein interactions between tan-1 and bcl-3. (A) Far Western blot of GST-bcl-3 polypeptides 
expressed in E. coli, using radiolabeled GST-TAR as a probe. Protein extracts from 400 #1 saturated bacterial cultures were 
loaded in each lane; Coomassie blu  staining of a duplicate gel showed equivalent amounts of protei  in the lanes. To demonstrate 
the specificity of binding, the membrane inthe top anel was incubated with probe in the presence of unlabeled GST and in the 
lower panel in the presence of unlabeled GST-TAR. At the bottom are shown fragments of bcl-3 joined to GST in various fusion 
polypeptides analyzed. The seven tandem ankyrin repeats in bcl-3 are indicated by shaded boxes. (B) Adsorption of 35S-labeled 
bcl-3 polypeptide translated in vivo to GST or GST-TAR bound to glutathione-Sepharose beads. In vitro translation products 
were separated by SDS-PAGE in a 6% gel immediately following translation ( ne 1) or after adsorption to glutathione-Sepharose 
beads preloaded with either GST-TAR (lane 2) or GST alone (lane 3). For lanes 2 and 3, fivefold more translation product was 
incubated with the beads as compared to the amount of product loaded directly in lane 1. The gel was dried and fluorographed. (C) 
Co-immunoprecipitation of tan-1 and epitope-tagged bcl-3 polypeptides from transfected cells. 293T cells were infected with 
pCGN-HA-BCL-3 and/or pCGN-TAN-1 expression vectors, some of which contained eletions in the TAN-1 cDNA. NP-40 
extracts were prepared after two days of culture, and HA-bcl-3 fusion polypeptide wasprecipitated with the 12CA5 antibody 
directed against the HA epitope. Whole extracts (left) and immunoprecipitates (right) were analyzed byWestern blotting as in Fig. 
2.25-fold more extract wasused for immunoprecipitation compared to the amounts of whole extract loaded directly on the gel. 
when we attempted to utilize the so-called yeast two- 
hybrid system (Zervos et al. 1993) to identify intracellu- 
lar ligands of tan-1. In preparation for using the two- 
hybrid system, we found that a "bait" plasmid express- 
ing a portion of the cytoplasmic domain of tan-1 (in- 
cluding the ankyrin repeats) fused to the DNA-binding 
protein LexA showed significant transcriptional activa- 
tion of a fl-galactosidase r porter gene. In fact, the 
degree of activation was in the range produced by a 
LexA-gal4 fusion protein, a natural strong transcrip- 
tional activator in Saccharomyces cerevisiae (Table 2). 
On the basis of these results, the intracellular domain of 
tan-1 apparently has the capacity, by itself, to activate 
transcription in yeast when it is supplied with the 
proper DNA-binding site. 
DISCUSSION 
Our studies have established several major points 
about TAN-1 and have also yielded a number of 
paradoxical observations. As demonstrated by experi- 
ments in which cDNA fragments of the TAN-1 gene 
were transduced into murine bone marrow cells that 
were then infused into irradiated hosts, truncated forms 
of the gene have potent oncogenic activity and exhibit a 
striking oncotropism for T-cell precursors. This ob- 
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Table 2. Transcription Activation by TAN-1  




LEXA-GA L4  1196,1744 
LEXA-TAN-1  1760-2124 1596,759 
On the left is the DNA insert ligated into the bait 
plasmid of the yeast wo-hybrid system. LEXA is the 
coding sequence for the E. coli DNA-binding protein. 
GAL4 is the full-length cDNA of the S. cerevisiae 
transcription factor. TAN-1 1760-2124 is the portion 
of the TAN-I cDNA containing codons 1760-2124 of 
the tan-1 protein (a region beginning on the intracel- 
lular side of the transmembrane domain and ending 
just carboxy-terminat to the ankyrin repeats. Each of 
these constructs was expressed in yeast and scored for 
the ability to increase the expression of a fl-galacosi- 
dase reporter gene (Zervos et al. 1993). fl-Galaetosi- 
dase activity was measured in arbitrary optical units. 
The results of two separate cultures for each bait 
plasmid are shown. 
servation confirms the inference that the 3' portion of 
this gene is related to the primary transforming event in 
the leukemia of those patients whose malignant T cells 
carry the t(7;9)(q34;q34.3). The frequency with which 
the recipient mice developed leukemia suggests that the 
oncogenic potential of this gene is high despite the fact 
the t(7;9)(q34;q34.3) occurs only in a minority of T-cell 
lymphoblastic neoplasms. However, the precise ef- 
ficiency of truncated TAN-1 in inducing transformation 
cannot be determined, since we do not yet know the 
number of murine bone marrow cells which actually 
acquire the TAN-1 cDNA in the transplant experi- 
ments or the identity of the target cell that is susceptible 
to transformation. The frequency of leukemias in the 
transplanted mice is probably also affected to some 
degree by the stochastic acquisition of other mutations, 
which, in addition to transduction of altered TAN-I, 
are probably required for malignant transformation of
T cells. However, the high overall incidence of 
leukemia in the transplanted mice and the relatively 
short latency period suggest hat the number of addi- 
tional genetic events required for transformation is
small. 
Given the potency of truncated TAN-1 in transform- 
ing T cells, the relative rarity of human leukemias with 
the t(7;9)(q34;q34.3) may reflect a narrow interval 
during T-cell development during which the transloca- 
tion can exert its oncogenic effect. Alternatively, some 
structural feature of DNA within the TAN-1 gene may 
make translocation in the critical region of the gene 
unlikely. These experiments also show that production 
of a chimeric gene product, for instance, between the/3 
T-cell receptor and tan-l, is not essential for trans- 
formation. In light of this fact, perhaps the proper 
positioning or activation of a promoter that can func- 
tion in T cells is the most important feature of translo- 
cations which will transform T cells through truncation 
of TAN-1. 
The structure and subcellular localization of the 
polypeptides encoded by TAN-1 cDNAs that exhibit 
transforming activity are difficult to reconcile in several 
respects with the tan-1 polypeptides detected in cells 
either containing or lacking the t(7;9) (q34;q34.3). Anal- 
yses of the tan-1 polypeptides incells with intact TAN-1 
genes show extensive proteolytic leavage of the full- 
length protein, p350, within the extracellular part of the 
protein near the transmembrane domain. The 
proteolytic product containing the intracellular portion 
of tan-l, p120, closely resembles the major truncated 
tan-1 polypeptide found in the cell line SUP-T1, con- 
taining the t(7;9)(q34;q34.3). Furthermore, both of 
these polypeptides are similar to the transforming poly- 
peptides expressed from the AECT+S(L)  and 
AECT + S(L) cDNAs. These observations suggest that 
p120 ought to be functionally similar to polypeptides 
encoded by transforming cDNAs. However, all evi- 
dence at present indicates that p120 has no transform- 
ing potential in T-lineage cells, even when generated 
presumably at high levels from viruses carrying a full- 
length TAN-1 cDNA in additional murine bone mar- 
row transplant experiments (W.S. Pear et al., unpubl.). 
One obvious difference between the normal p120 
and the truncated product in SUP-T1 is the subcellular 
location of the proteins. At least in transfected cells, 
p120 seems to be located predominantly in the cyto- 
plasm, whereas truncated tan-1 in SUP-T1 is found 
primarily in the nucleus. These locations are consistent 
with the divergent mechanisms by which the proteins 
are produced, p120 is presumably derived from p350 
after insertion into the membrane of the endoplasmic 
reticulum, but the truncated product in SUP-T1 may be 
inefficiently.inserted into membranes due to the lack of 
a signal peptide. However, like p120, both the AECT § 
S(L) and AECT + S(L) polypeptides in transformed 
murine T cells accumulate preferentially in the cyto- 
plasm, as expected on the basis of the structure of the 
encoded proteins. Therefore, neither the cytoplasmic 
location nor the membrane association appears to ac- 
count for the inability of p120 to transform T cells, 
despite the resemblance of this polypeptide to on- 
cogenic versions of tan-1. This paradox suggests that 
p120 may differ from transforming polypeptides in 
tertiary structure and/or in its ability to associate with 
unknown regulatory factors involved in tan-1 signaling. 
The teleologic reason for the intense nuclear localiza- 
tion of the truncated tan-1 polypeptides in SUP-T1 is 
not clear. As discussed above, abundant intranuclear 
tan-1 polypeptide does not seem to be required for 
transformation. Therefore, if transformation i dicates 
some exaggerated physiological effect of tan-l, nuclear 
localization is not a prominent feature of tan-1 func- 
tion. Moreover, no cross-reacting tan-1 polypeptide 
could be detected by immunofluorescence in the nuclei 
of transfected cells expressing large amounts of p350 
and p120. 
Nevertheless, the presence of some nuclear tan-1 
polypeptide cannot be ruled out. It may be that small 
amounts of tan-1 polypeptide do move to the nucleus 
and that very little protein within the nucleus is neces- 
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sary for transformation. This scenario is reminiscent of 
the situation recently described for the sterol-regula- 
tory element binding protein (SREBP-1) (Wang et al. 
1994). The precursor form of this protein is inserted 
into the endoplasmic reticulum and nuclear envelope of 
cells, where it is proteolytically processed in response to 
low sterol levels. A fragment of the processed protein 
migrates to the nucleus and up-regulates expression of 
genes for enzymes involved in sterol synthesis. SREBP- 
1 is very unstable within the nucleus, being undetect- 
able in the absence of a specific inhibitor that blocks 
intranuclear degradation of the protein. 
The analogy of tan-1 to SREBP-1 would be even 
more complete if tan-1 served some role in transcrip- 
tion activation, as suggested by our data on the ability 
of tan-1 to activate transcription i yeast. The relevance 
of transcriptional ctivity detected in this heterologous 
system remains to be determined, although the mag- 
nitude of activity displayed by the tan-1 sequences i
unusual for a purely artifactual result. If tan-1 possesses 
physiological intranuclear activity of any kind, such 
activity would depend on an additional cleavage of the 
full-length or previously processed protein at some 
position on the cytoplasmic side of the transmembrane 
domain in order to free the polypeptide from the 
membrane. To date, we have detected no evidence of 
such a cleavage. On the other hand, the presence of the 
highly efficient nuclear localization signals identified 
within the intracellular portion of the tan-1 protein 
would certainly be consistent with intranuclear func- 
tion. The alternative xplanation for these signals is 
that they are merely fortuitous. 
Studies of notch in Drosophila suggest that this 
protein transmits developmental signals across the plas- 
ma membrane of cells in a number of tissues. This 
transduction is likely to involve the binding ligands on 
both the extra- and intracellular sides of the membrane. 
In humans, the nature of the extracellular ligand is 
completely unknown; however, our work has demon- 
strated that bcl-3 is a strong candidate for an intracellu- 
lar ligand. The interaction between bcl-3 and tan-1 was 
revealed through a screen for possible ligands ex- 
pressed by a library of human endothelial cell cDNAs. 
This library was utilized for this purpose solely because 
it was known to contain TAN-1 cDNAs as well as 
cDNAs for a wide variety of other genes. Despite the 
random and unbiased nature of this screen, the protein 
detected to bind to the intracellular portion of tan-1 is 
one associated with lymphocytes, having originally 
been discovered as the product of a gene lying at the 
breakpoint of a translocation, t(14;19)(q32;q13), found 
in the neoplastic B cells of certain cases of chronic 
lymphocytic leukemia (McKeithan et al. 1987, 1990). 
The binding of bcl-3 to tan-1 has at least two im- 
portant implications. First, interaction between bcl-3 
and tan-1 occurs through ankyrin repeats present in 
both proteins, a type of interaction that has not been 
described previously. Second, since bcl-3 has been 
shown to be a regulator of NF-KB (Franzoso et al. 1992; 
Kerr et al. 1992; Fujita et al. 1993; Nolan et al. 1993), 
interaction of tan-1 with bcl-3 suggests that tan-1 may 
be involved indirectly in the transcriptional control of 
genes regulated by NF-KB. The role of tan-1 within the 
NF-KB pathway of gene regulation is not evident at this 
time. Perhaps, under certain circumstances, tan-1 
serves to sequester bcl-3 in a perinuclear location and 
thereby alters transcription of genes under NF-KB 
control. This model by no means eliminates the possi- 
bility of other actions by tan-1 in lymphoid or other 
tissues. However, involvement of tan-1 in the NF-KB 
pathway does highlight he expanding number of posi- 
tions at which this pathway is vulnerable to genetic 
modifications which can contribute to malignant trans- 
formation. Along with BCL-3 and the rel family of 
oncogenes (Nolan and Baltimore 1992), including 
LYT-IO, another translocation-associated human on- 
cogene (Neri et al. 1991), TAN-I brings to three the 
number of genes with transforming potential related to 
the NF-KB pathway. Very likely, additional genes 
producing products that impinge on NF-KB will be 
found to have similar properties in the near future. 
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